Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11648318 Anti-transferrin receptor (TFR) antibody and uses thereof

Patent 11648318 was granted and assigned to Dyne Therapeutics on May, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies
0
Edits on 2 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12102687 Muscle targeting complexes and uses thereof for treating myotonic dystrophy
0
Edits on 27 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Jun, 2024
Edits on 19 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2024
Edits on 12 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12005124 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
Edits on 22 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11986537 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
Edits on 1 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 May, 2024
Edits on 21 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11931421 Muscle targeting complexes and formulations for treating myotonic dystrophy
0
Edits on 2 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11911484 Muscle targeting complexes and uses thereof for treating myotonic dystrophy
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11833217 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
Edits on 14 Aug, 2023
"Add patent inventor"
Golden AI profile picture
Golden AI
edited on 14 Aug, 2023
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Brendan Quinn0
Cody A. Desjardins0
John Najim0
Mohammed T. Qatanani0
Romesh R. Subramanian0
Timothy Weeden0
Edits on 17 May, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 17 May, 2023
Edits made to:
Infobox (+35 properties)
Article (+242 characters)
‌

 US Patent 11648318 Anti-transferrin receptor (TFR) antibody and uses thereof

Article

Aspects of the disclosure relate to antibodies that bind to transferrin receptor (e.g., transferrin receptor 1) and complexes comprising the antibody covalently linked to a molecular payload. Methods of using the antibodies are also provided.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Dyne Therapeutics
Dyne Therapeutics
0
Current Assignee
Dyne Therapeutics
Dyne Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116483180
Date of Patent
May 16, 2023
0
Patent Application Number
178113960
Date Filed
July 8, 2022
0
Patent Citations
‌
US Patent 11111309 Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4
0
‌
US Patent 11168141 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 10131682 Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
0
‌
US Patent 10238753 Antisense conjugates for decreasing expression of DMPK
0
‌
US Patent 10239807 Fused cyclooctyne compounds and their use in metal-free click reactions
0
‌
US Patent 10266502 Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyne
0
‌
US Patent 11230605 Anti-TfR antibodies and their use in treating proliferative and inflammatory disorders
0
‌
US Patent 10434111 Compositions and methods for modification of biomolecules
0
‌
US Patent 10550188 Nucleic acid-polypeptide compositions and uses thereof
0
‌
US Patent 11248056 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 11286305 Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA
0
‌
US Patent 11369689 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 11390682 Methods of intravenouisly delivering anti-transferrin antibody/oligonucleotide complexes to subjects having muscular dystrophy
0
‌
US Patent 11497815 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 11518816 Methods of delivering an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy
0
Patent Primary Examiner
‌
Phuong Huynh
0
CPC Code
‌
C07K 2317/92
0
‌
C07K 2317/55
0
‌
C07K 2317/24
0
‌
C07K 16/2881
0
‌
A61K 47/6889
0
‌
A61K 47/6849
0
‌
A61K 47/6811
0
‌
A61K 47/6807
0
‌
A61P 21/00
0
‌
A61K 2039/545
0
‌
A61K 2039/505
0

Find more entities like US Patent 11648318 Anti-transferrin receptor (TFR) antibody and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.